takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Stephen W. Kaldor Ph.D.
Advisor, Achaogen, Inc.
|Age||Total Calculated Compensation||This person is connected to 5 board members in 1 different organizations across 9 different industries.|
See Board Relationships
Dr. Stephen W. Kaldor, also known as Steve, serves as Acting Chief Executive Officer Quanticel Pharmaceuticals, Inc. Dr. Kaldor serves as an Advisor of Achaogen, Inc. He is a Venture Partner at Versant Ventures. e also serves as an Advisor at Thomas, McNerney & Partners and advises on drug discovery. He was a Venture Partner at Versant Ventures. He gained over 12 years of research and development, drug discovery and development experience at Eli Lilly and Company both ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*
Former Chief Executive Officer, President and Executive Director
Director, Member of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|